Mycophenolate mofetil treatment in a patient with frequently relapsing nephrotic syndrome

Mycophenolate mofetil treatment in a patient with frequently relapsing nephrotic syndrome - Mycophenolate mofetil treatment in a patient with frequently relapsing nephrotic syndrome

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000007511

Enrollment

Registered

2012-04-01

Start date

2012-03-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

frequently relapsing nephrotic syndrome

Interventions

Administration of mycophenolate mofetil 500 to 1000mg a day

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: frequently relapsing nephrotic syndrome

Exclusion criteria

Exclusion criteria: No exclusion criteria

Design outcomes

Primary

Measure	Time frame
Time to frequent relapse	—

Secondary

Measure	Time frame
Time to relapse side effect	—

Countries

Japan

Contacts

Public ContactHitoshi Nakazato

Kumamoto University, Faculty of Life Sciences Department of Pediatrics

hnakazat@fc.kuh.kumamoto-u.ac.jp096-373-5191

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026